Efficacy of early rituximab treatment in anti-mGluR1 encephalitis: a case report

Efficacy of early rituximab treatment in anti-mGluR1 encephalitis: a case report

Abstract Background Anti-mGluR1 encephalitis is a form of autoimmune encephalitis, with limited reports globally and only two cases reported from Japan. There are uncertainties regarding the optimal immunosuppressive agents and individual drug responses. Herein, we report a case of anti-mGluR1 encep...

Full description

Saved in:
Bibliographic Details
Main Authors: Kazuki Yamada, Hiroaki Yaguchi, Shuntaro Nakamura, Kazuhiro Horiuchi, Shintaro Fujii, Taichi Nomura, Akihiko Kudo, Akira Takekoshi, Nobuaki Yoshikura, Akio Kimura, Takayoshi Shimohata, Ichiro Yabe
Format: Article
Language:English
Published: BMC 2025-08-01
Series:BMC Neurology
Subjects:
Anti-mGluR1 encephalitis
Cerebellar blood flow
MGluR1 antibody
Rituximab
Online Access:https://doi.org/10.1186/s12883-025-04345-8
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12883-025-04345-8

Similar Items